{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-23-000002","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.188122+00:00","generated_at":"2026-06-20T17:33:59.414226+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Exagen provides preliminary Q4 and FY 2022 AVISE CTD unit volumes, Q1 2023 revenue guidance","bullets":["Delivered ~33,800 AVISE CTD units in Q4 2022; ~135,000 units for full year 2022.","Expects Q1 2023 revenue between $8.2M and $9.2M.","Estimates profitability achievable at $75M annual revenue assuming 60% gross margin."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-23-000002","json":"https://secwatch.observer/filing/0001274737-23-000002.json","markdown":"https://secwatch.observer/filing/0001274737-23-000002.md","text":"https://secwatch.observer/filing/0001274737-23-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/0001274737-23-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/exdx-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:33:59.414226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd961bd49c88f5303d38a528084b47bf54d6b302","claim":"EXAGEN INC. reported preliminary financial results for the three months ended December 31, 2022.","evidence_excerpt":"The Company is providing certain preliminary financial information and results of operations for the three months and year ended December 31, 2022, based on currently available information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/0001274737-23-000002-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended December 31, 2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"f35d1ca3c55a42bef0aae4872639dea4b2a6ae30","claim":"EXAGEN INC. reported preliminary financial results for the year ended December 31, 2022.","evidence_excerpt":"The Company is providing certain preliminary financial information and results of operations for the three months and year ended December 31, 2022, based on currently available information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/0001274737-23-000002-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}